Covered recipient · General Payments record
SAIDA KHAMOOSHI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2022–2023
$699.60
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $581.67 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $125.00 | 1 |
| GlaxoSmithKline, LLC. | $119.73 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $109.38 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $77.57 | 2 |
| COLOPLAST CORP | $70.26 | 1 |
| Neurocrine BioSciences, Inc. | $62.21 | 1 |
| EAGLE PHARMACEUTICALS, INC. | $17.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $125.00 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020823953 | CMS |
| Boston Scientific Corporation | $109.38 | 07/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022532085 | CMS |
| Coloplast Corp | $70.26 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993619205 | CMS |
| EAGLE PHARMACEUTICALS, INC. | $17.52 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033270849 | CMS |
| GlaxoSmithKline, LLC. | $119.73 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004191743 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $28.61 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034545215 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $48.96 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034545209 | CMS |
| Neurocrine Biosciences, Inc. | $62.21 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052335517 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.